HomeCompareEEMO vs JNJ

EEMO vs JNJ: Dividend Comparison 2026

EEMO yields 2.47% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EEMO wins by $3.3K in total portfolio value
10 years
EEMO
EEMO
● Live price
2.47%
Share price
$16.26
Annual div
$0.40
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$289.61
Full EEMO calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EEMO vs JNJ

📍 EEMO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEEMOJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EEMO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EEMO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EEMO
Annual income on $10K today (after 15% tax)
$209.89/yr
After 10yr DRIP, annual income (after tax)
$246.17/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $457.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EEMO + JNJ for your $10,000?

EEMO: 50%JNJ: 50%
100% JNJ50/50100% EEMO
Portfolio after 10yr
$21.7K
Annual income
$558.69/yr
Blended yield
2.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EEMO
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EEMO buys
0
JNJ buys
0
No recent congressional trades found for EEMO or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEEMOJNJ
Forward yield2.47%3.36%
Annual dividend / share$0.40$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$23.4K$20.0K
Annual income after 10y$289.61$827.78
Total dividends collected$2.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EEMO vs JNJ ($10,000, DRIP)

YearEEMO PortfolioEEMO Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,947$246.93$10,676$355.77+$271.00EEMO
2$11,966$252.63$11,407$389.39+$559.00EEMO
3$13,062$258.08$12,198$426.53+$864.00EEMO
4$14,239$263.28$13,056$467.62+$1.2KEEMO
5$15,504$268.24$13,987$513.12+$1.5KEEMO
6$16,862$272.96$14,998$563.56+$1.9KEEMO
7$18,320$277.45$16,098$619.52+$2.2KEEMO
8$19,884$281.72$17,295$681.69+$2.6KEEMO
9$21,562$285.77$18,599$750.82+$3.0KEEMO
10$23,361$289.61$20,022$827.78+$3.3KEEMO

EEMO vs JNJ: Complete Analysis 2026

EEMOStock

The Invesco S&P Emerging Markets Momentum ETF (Fund) is based on the S&P Momentum Emerging Plus LargeMidCap Index (Index). The Fund generally will invest at least 90% of its total assets in the securities of companies that comprise the Index, as well as American depositary receipts ("ADRs") and global depositary receipts ("GDRs") that represent securities in the Index. The Fund anticipates that at times it may invest a significant portion of its investments in ADRs and GDRs that are based on the securities included in the Index. The Fund and the Index are rebalanced and reconstituted semi-annually on the third Friday of March and September.

Full EEMO Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EEMO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EEMO vs SCHDEEMO vs JEPIEEMO vs OEEMO vs KOEEMO vs MAINEEMO vs ABBVEEMO vs MRKEEMO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.